317 related articles for article (PubMed ID: 27816647)
21. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
[TBL] [Abstract][Full Text] [Related]
22. Polypyridyl Ruthenium(II) complex-induced mitochondrial membrane potential dissipation activates DNA damage-mediated apoptosis to inhibit liver cancer.
Li Y; Wu Q; Yu G; Li L; Zhao X; Huang X; Mei W
Eur J Med Chem; 2019 Feb; 164():282-291. PubMed ID: 30599417
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic activity, DNA damage, cellular uptake, apoptosis and western blot analysis of ruthenium(II) polypyridyl complex against human lung decarcinoma A549 cell.
Lai SH; Jiang GB; Yao JH; Li W; Han BJ; Zhang C; Zeng CC; Liu YJ
J Inorg Biochem; 2015 Nov; 152():1-9. PubMed ID: 26291582
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization, DNA interaction, antioxidant and anticancer activity studies of ruthenium(II) polypyridyl complexes.
Jiang GB; Xie YY; Lin GJ; Huang HL; Liang ZH; Liu YJ
J Photochem Photobiol B; 2013 Dec; 129():48-56. PubMed ID: 24177204
[TBL] [Abstract][Full Text] [Related]
25. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.
Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ
J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of polypyridine ruthenium(II) complexes and anticancer efficacy studies in vivo and in vitro.
Liang L; Wu X; Shi C; Wen H; Wu S; Chen J; Huang C; Wang Y; Liu Y
J Inorg Biochem; 2022 Nov; 236():111963. PubMed ID: 35988387
[TBL] [Abstract][Full Text] [Related]
27. In vitro cytotoxicity, cellular uptake, reactive oxygen species and cell cycle arrest studies of novel ruthenium(II) polypyridyl complexes towards A549 lung cancer cell line.
Qasim Warraich M; Ghion A; Perdisatt L; O'Neill L; Casey A; O'Connor C
Drug Chem Toxicol; 2021 May; 44(3):319-329. PubMed ID: 30991856
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
30. Anticancer activity studies of a ruthenium(II) polypyridyl complex against human hepatocellular (BEL-7402) cells.
Li W; Han BJ; Yao JH; Jiang GB; Lin GJ; Xie YY; Huang HL; Liu YJ
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():127-34. PubMed ID: 26037497
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic effects of procyanidins from Castanea mollissima Bl. shell on human hepatoma G2 cells in vitro.
Zhang H; Ke J; Shao T; Li J; Duan Y; He Y; Zhang C; Chen G; Sun G; Sun X
Food Chem Toxicol; 2014 Feb; 64():166-76. PubMed ID: 24291453
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.
Chen Y; Qin MY; Wu JH; Wang L; Chao H; Ji LN; Xu AL
Eur J Med Chem; 2013; 70():120-9. PubMed ID: 24141202
[TBL] [Abstract][Full Text] [Related]
33. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD
J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374
[TBL] [Abstract][Full Text] [Related]
34. Synthetic Dibenzoxanthene Derivatives Induce Apoptosis Through Mitochondrial Pathway in Human Hepatocellular Cancer Cells.
Jia Z; Yang HH; Liu YJ; Wang XZ
Appl Biochem Biotechnol; 2018 Sep; 186(1):145-160. PubMed ID: 29527627
[TBL] [Abstract][Full Text] [Related]
35. DNA interaction, antioxidant activity, and bioactivity studies of two ruthenium(II) complexes.
Han BJ; Jiang GB; Yao JH; Li W; Wang J; Huang HL; Liu YJ
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():840-9. PubMed ID: 25150435
[TBL] [Abstract][Full Text] [Related]
36. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
[TBL] [Abstract][Full Text] [Related]
37. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
[TBL] [Abstract][Full Text] [Related]
38. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes.
Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y
Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162
[TBL] [Abstract][Full Text] [Related]
39. The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes.
Qian C; Wang JQ; Song CL; Wang LL; Ji LN; Chao H
Metallomics; 2013 Jun; 5(7):844-54. PubMed ID: 23483103
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, Spectral Properties and DFT Calculations of new Ruthenium (II) Polypyridyl Complexes; DNA Binding Affinity and in Vitro Cytotoxicity Activity.
Mallepally RR; Chintakuntla N; Putta VR; K N; Vuradi RK; P M; S SS; Chitumalla RK; Jang J; Penumaka N; Sirasani S
J Fluoresc; 2017 Jul; 27(4):1513-1530. PubMed ID: 28432633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
